IXICO plc (AIM:IXI)
London · Delayed Price · Currency is GBP · Price in GBX 7.76
-0.05 (-0.58%)
Mar 26, 2026, 9:49 AM GMT
IXICO Market Cap
IXICO has a market cap or net worth of 7.23 million as of March 26, 2026. Its market cap has decreased by -16.13% in one year.
Market Cap
7.23M
Enterprise Value
3.87M
Revenue
6.53M
Ranking
n/a
PE Ratio
n/a
Stock Price
7.76
Market Cap Chart
Since October 15, 2013, IXICO's market cap has decreased from 8.82M to 7.23M, a decrease of -18.07%. That is a compound annual growth rate of -1.59%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 25, 2026 | 7.23M | -33.62% |
| Dec 31, 2025 | 10.89M | - |
| Dec 31, 2024 | 10.89M | 80.16% |
| Dec 29, 2023 | 6.04M | -50.98% |
| Dec 30, 2022 | 12.33M | -57.32% |
| Dec 31, 2021 | 28.89M | -40.15% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Aptamer Group | 17.53M |
| Fusion Antibodies | 15.00M |
| Cizzle Biotechnology Holdings | 11.10M |
| Genflow Biosciences | 9.91M |
| Oxford BioDynamics | 9.01M |
| Futura Medical | 7.39M |
| CRISM Therapeutics | 6.60M |
| OptiBiotix Health | 5.42M |